Note: Descriptions are shown in the official language in which they were submitted.
2014035
MELT PROCESSABLE POLYURETHANEUREA COPOLYMERS
AND METHOD FOR THEIR PREPARATION
BACKGROUND OF THE INVENTION
1. Field of the Invention. This invention
relates to copolymers, and more specifically relates to
polyurethaneureas which may be extruded and molded in
melt form and a method for their preparation.
2. Backqround of the Invention. Polyurethane
block copolymers possess an outstanding balance of
physical and mechanical properties and superior blood
compatibility compared to other polymers such as
silicone rubber, polyethylene, polyvinyl chloride and
perfluorinated polymers. As a result, they have come
to the fore as the preferred polymeric biomaterials for
fabrication of various medical device components. Some
important device applications for polyurethanes include
peripheral and central venous catheters, coatings for
heart pacemaker leads and the Jarvik heart.
Polyurethanes are synthesized from three basic
components, a polyisocyanate, a macroglycol and an
extender, usually a low molecular weight diol, diamine,
aminoalcohol or water. If the extender is a diol, the
polyurethane consists entirely of urethane linkages.
If the extender is water, aminoalcohol or a diamine,
both urethane and urea linkages are present and the
polyurethane is more accurately and conventionally
termed a polyurethaneurea. In this disclosure,
polyurethaneurea will hereinafter be abbreviated as PW.
201 4035
- 2 -
Polyurethanes develop microdomains conventionally
termed hard segments and soft segments, and as a result
are often referred to as segmented polyurethanes. The
hard segments form by localization of the portions of
the polymer molecules which include the isocyanate and
extender components and are generally of high
crystallinity. The soft segments form from the
polyether glycol portions of the polymer chains and
generally are either noncrystalline or of low
crystallinity. One of the factors which determines the
properties of the copolymer is the ratio of hard and
soft segments.
Exemplary of important diol extended
polyurethanes are: Vialon~ (Becton Dickinson Polymer
Research), Pellethane~ (Dow Chemical Co.,) and
Tecoflex~ (Thermedics Inc.). These products
typically have good blood compatibility, but, with the
exception of Vialon~, generally require processing
additives such as antioxidants and detackifiers, a
potential disadvantage for use in biomedical articles.
They are, however, thermoplastic and therefore may be
melt extruded and injection molded.
Diol extended thermoplastic polyurethanes are
conventionally manufactured by operationally simple and
economical bulk or one-shot polymerization processes
wherein all the ingredients are combined, mixed and
reacted. P W s, although commercially prepared by a
two-step procedure, described below, have also been
prepared by a one-shot continuous process using a
catalyst (U.S. Patent No. 3,642,964 to Rausch et al.).
The catalyst, because is is generally inherently toxic,
cannot be present in PW s to be fabricated into
biomedical articles.
201 4035
The conventional two-step preparation of P Ws is
generally carried out by reacting the isocyanate and
macroglycol in a solvent to give a prepolymer followed
by chain ~extension with the diamine or aminoalcohol.
Exemplary of the two-step procedure is the disclosure
of Gilding et al. in U.S. Patent No. 4,062,834.
Several disadvantages are encountered in the
two-step process. First, the process generally
requires a solvent, usually toxic dimethylacetamide
(DMAC). Second, as pointed out by Ward et al.
~Polyurethanes in Biomedical Enqineering, H. Planck, G.
Egbers and I. Syre, ed., Elsevier Science Publishers
B.V., Amsterdam, 1984) even reagent grade solvents
contain enough water as an impurity to hydrolyze a
significant portion of the isocyanate groups to amine
groups which react with other isocyanate residues to
form urea linkages of different structures than those
obtained from the diamine extender. The resulting
mixed hard segments complicate the structure of the
polymers and increase the likelihood of batch to batch
variations in properties.
A PW well-known as an industrial fiber (Lycra~
DuPont de Nemours and Co.) has been extensively studied
under the trade name Biomer~ (Ethicon Corp.) for
fabrication of various biomedical devices. A review of
these studies and the many salubrious properties of PW
has been presented by Phillips et al., The Use of
Seqmented Polyurethane In Ventricular Assist Devices
and Artificial Hearts, in Synthetic Biomedical
Polymers, M. Szycher and W. J. Robinson, ed. Technomic
Publishing Co., Inc., Westport, CT, 1980, page 39.
However, as stated by Phillips et al., Biomer~
- 201 4035
presents some fabrication difficulties that limit production
t~chniques. Biomer (Trademark) has a melt temperature higher
than the decomposition temperature of the urethane functionality
and therefore can be spun or cast only from solution, i.e., it
cannot be melt extruded or injection molded. Severe limitations
are thereby imposed on its fabrication latitude. Further, it is
essentially insoluble in all solvents except DMAC which of course
must be completely removed if the product is to be used in a
biomedical article.
Taller et al., in RefieArch Disclosure No. 12,823, December
1974, and Short et al. in U.S. Patent No. 4,522,986, disclose PW
compositions prepared by the two-step prepolymer tech~;que from
a diisocyanate, a polyol and monoethanolamine as extender.
Ward et al. (supra) discloses a new P W formulation for
biomedical use consisting of a blend of PW and an additive
surfactant polymer.
~s~
201 4035
4a
GB 2082069-A discloses the use of ext~n~er mixtures
comprising ortho-alkyl aromatic diamines and low mole~lAr weight
diols to give thermosetting P W compositions suited for reaction
injection molding.
DE-OLS 2635400 discloses a heterogenous reaction to give PW
compositions, using reactive aromatic diamine extenders with
polyisocyanate/high molecular weight polyol mixes optionally
further containing a low molecular weight polyol. In the typical
process, a prepolymer is formed from the polyisocyanate/high
molec~llAr weight polyol mix for sllhce~uent reaction as a melt
with solid reactive aromatic diamine.
There is a need for a one-shot, solvent-free and
catalyst-free polymerization method to prepare melt procefisAhle
PUU having the desirable properties of both diol extended and
diamine extended P W. The present invention fulfils this need.
SUMMARY OF THE lNVh~llON
One aspect of the present invention is a melt procecsAhle
PW prepared by reaction of a polyisocyanate, a macroglycol
selected from polyester glycol, polylactone glycol, polyether
glycol and silicone glycol a chain ext~n~ing diol and a chain
extending non aromatic diamine. Preferred PWs are prepared from
a diisocyanate such as 4, 4'-diphenylmethane diisocyanate (MDI)
and a polyether glycol, such as polyethylene glycol (PEG) or
polytetramethyleneoxide
'.'i,
: L '
201 4035
- 5 -
glycol (PTMO). The macroglycol may be wholly or in
part a silicone glycol. Preferred diol extenders are
ethylene glycol (EG) and 1,4-butanediol (BDO).
Preferred diamine extenders are ethylenediamine (EDA)
and 2-methylpentamethylene diamine (MPMD). Water may
be included in the reaction mixture and, in the form of
moist air, may also serve to cure the polymer. The
polymer may include various additives, such as a
radiopaque agent.
Another aspect of the invention is a method to
prepare the PW of the invention. The preferred method
is a one-pot reaction in which all the components are
combined with efficient stirring. An exotherm takes
place during the polymerization reaction, after which
the polymer may be transferred to a tray for
spontaneous moisture cure at an appropriate temperature.
Thus the method of the invention provides a
low-cost, catalyst-free and solvent-free bulk or
one-shot method for preparing melt-processable PW s.
In contrast, the previously disclosed two-step method
for preparation of P W s requires a solvent, requires
careful control of various reaction parameters, and
provides a PW which cannot be melt processed and
instead must be solution cast or solution extruded.
The PWs of the invention are melt processable over a
wide range of hard segments and possess higher tensile
properties than PW s extended with amine or diol only.
Medical device components melt extruded from the
inventive PWs exhibit an excellent l~el of
hemocompatibility and show a very low tendency toward
tac~iness, even when of low hard segment content. In
contrast, most low hard segment polyurethanes excluding
20 t 4035
Vialon~ and polyurethaneureas of the known art
contain solvents, catalysts and detackifiers that can
leach out of device components with potentially
deleterious effect on blood and tissue compatibility.
In addition to having advantages accruing from
conventional melt processing and solution coating
fabrication techniques, the PW s of the invention may
be developed and expanded into a broad new class of
polymeric biomaterials and devices through polymer
alloys, chemical modification, grafting, surface
coating treatments and co-extrusion. Such material
should potentially provide a novel range of
physicalJmechanical properties, enhanced blood and
tissue compatibility as well as selective moisture
vapor, gas transmission and controlled release
characteristics.
DETAILED DESCRIPTION OF T~IE INVENTION
While this invention is satisfied by embodiments
in many different forms, there will herein be described
in detail preferred embodiments of the invention with
the understanding that the present disclosure is to be
considered as exemplary of the principles of the
invention and is not intended to limit the invention to
the embodiments described. The scope of the invention
will be measured by the appended claims and their
equivalents.
In accordance with the method of the present
invention, P Ws which may be processed by melt
techniques such as extrusion and insert and injection
molding are synthesized by a simple reproducible
- 20`1 403~
one-pot bulk polymerization procedure without a solvent
or catalyst. The method may be applied to any
formulation which includes polyisocyanates and
macroglycols polymerized and chain extended with a
combination of a diol and a dia~ine, and optionally
with water. The novel polymers of the invention may be
used in a number of applications requiring soft,
elastomeric, blood compatible, and tissue compatible
polymers. For example, they have excellent
applicability in virtually all central venous access
catheter products, urinary catheters, vascular grafts,
long term implantable catheters, as coatings or
components of other implantable devices, elastomeric
gloves, and condoms. These polymers are also useful
for products requiring a harder material such as
hemodialysis catheters, introducer catheters,
obturators, and peripheral catheters.
Polyisocyanates useful in the present invention
may have two or more isocyanate groups. Preferred
polyisocyanates are aromatic or alicyclic
diisocyanates, such as MDI, toluene diisocyanate,
isophorone diisocyanate, methylene bis (4-cyclohexyl
isocyanate), he~methylene diisocyanate and the like.
Of these, MDI is preferred.
Useful macroglycols are polyester glycols,
polylactone glycols and polyether glycols. These
macroglycols are well-known in the art and many are
commercially available. Preferred macroglycols are
polyethers having a molecule weight of about 500 to
8,000. A preferred polyether is PEG. The most
preferred polyether is PTMO having a molecular weight
of about 500 to 3,000, preferably about 1,000 to
~01 403~
-
- 8 -
2,000. These products are available commercially under
the trade names Polymeg~ (Quaker Oats Co., Chemical
Division) and Terathane~ (DuPont), respectively.
Another class of useful macroglycols is the
silicone glycol class. These products likewise are
well-known, and representative examples are described
in U.S. Patent No. 4,647,643 to Zdrahala et al. A
particularly useful silicone glycol is commercially
available from Dow Corning Corp. under the designation
4-3667 fluid (formerly Q4-3667). This product will
hereinafter be referred to as Q-4. Those formulations
of the invention which include a silicone glycol may
have from 0 to 20% of the total weight of the
formulation in the form of the silicone glycol.
The chain extender component of the inventive PW
may include both a low molecular weight branched or
unbranched diol and diamine of up to 12 carbon atoms.
Representative nonlimiting examples of chain extenders
are BDO; EG; diethylene glycol; triethylene glycol;
1,2-propanediol; 1,3-propanediol; 1,6-hexanediol;
1,4-bis-hydroxymethyl cyclohexane, hydroquinone
dihydroxyethyl ether, EDA, hexamethylenediamine (HDA),
octamethylenediamine (ODA), dodecamethylenediamine
(DDA), 1,2-, 1,3- and 1,4-phenylenediamine (PDA) and
MPMD (commercially available from DuPont, Wilmington,
Delaware, under the trade name Dytek A~). The most
preferred extenders are BDO, HDA, ODA, DDA and MPMD.
The ratio of diol to diamine in the mixture of
extenders may be about 1:1,000 to 1,000:1, preferably
about 1:10 to 10:1, most preferably about 1:2 to 2:1.
In the P W of the invention, the diol chain
201 4035
extender provides melt processability and contributes
to the strength of the polymer. On the other hand, the
diamine extender provides blood co~patibility which
makes articles fabricated from the PW of the invention
particularly suitable for blood-contacting operations.
The diisocyanate and chain extender make up the
hard segment of the P W composition. Compositions
which may be prepared by the method of the invention
may have hard segments of from 20 to 75% by weight of
the total weight of the formulation. Preferred
formulations include hard segments of 27 to 35% by
weight.
The ratio of the ingredients which may be reacted
in accordance with the method of the invention is based
on the reaction of one isocyanate group with one
alcohol or amino group from the macroglycol or
extenders. Thus, the ratio of the total isocyanate
groups in the diisocyanate to the total hydroxyl and
amino groups present in both the macroglycol and the
extender components is conventionally referred to as
the isocyanate index (II) and may be from about 80 to
140, preferably from about 110 to 140, most preferably
about 120. The quantities of the ingredients to be
mixed may be calculated from the predetermined ratio of
desired hard and soft segments and the known equivalent
weights of the diisocyanate, macroglycol and diol and
diamine extenders. Excess isocyanate groups present in
formulations of high II may be reacted with water
during the curing step, as described below.
It will be appreciated by one skilled in the art
that blocks of both the diol and diamine extenders are
201 4035
- 10 -
present in the polyurethaneurea of the invention.
Thus, for example, the PW may have as a representative
structure
- MDI - PTMO - MDI - MPMD - MDI - BDO - MDI
with the understanding that the hyphens represent
covalent bonds formed between the indicated reaction
components and that the terminal isocyanate groups are
hydrolyzed by chain extending water in the formulation
or preferably during a moisture cure to amino groups
which may react with other isocyanate groups to give
blocks of additional hard segment.
In conventional bulk or one-shot or one-step
polymerization processes, all of the ingredients are
combined at the beginning of the process and sub3ected,
usually with stirring, to a polymerization catalyst.
The present inventors have discovered, in contrast to
the prior art, that PW s which are melt processable may
be obtained by a simple one-pot procedure without
catalyst or solvent when the chain is extended with a
mixture of a diol and a diamine. Conventional
catalysts in the art, for example, organometallic
compounds such as dibutyl tin dilaurate, are toxic and
leachable and may cause deletrious effects in blood-
contacting elements fabricated from prior art catalyst-
containing PW . By avoiding use of a catalyst, PW s ofthe invention are purer and potentially less toxic than
those of the prior art and are suitable for fabrication
of biomedical devices.
In one preferred process of the invention,
conventional polymerization equipment is charged with a
mixture of the macroglycol and extenders in proportions
predetermined in accordance with the desired hard
11 201 4035
segment-soft segment ratio. With vigorous stirring, the
ocyanate may be added all at once. If the reaction does not
start spontaneously, the mixture may be heated sufficiently to
in~llce an exothermic reaction. The reaction mixture may be
stirred vigorously until the exotherm is complete and the
temperature begins to drop off, generally for about 1 to S
minutes. The clear homogeneous melt, while still hot, may
advantageously be removed from the reactor prior to curing.
The reaction may be carried out for about 1 second to 10
minutes, preferably about 15 fi~cQn~e to 5 minutes, most
preferably for about 1 to 2 minutes. In general, the exotherm
reaches about lOO C before subsiding.
Any conventional method may be used to effect curing.
Preferably, the melt is simply set aside for a suitable time and
temperature, as, for example, from ambient to about 60C and for
about 1 hour to 20 days, to be cured by atmospheric moisture.
Any polymerization equipment or techn i que which provides a
clear melt at the conclusion of the exotherm is contemplated to
fall within the scope of the
201 4~35
- 12 -
invention. Preferred equipment includes a multi-paddle
shaft driven at high rotation rate by a motor.
Exemplary of such a system is the Fluidyne Model 63014
Microshot Elastomer Processing System.
The polyurethane resins of the invention may be
fabricated into film, tubing and other forms by
conventional thermoplastic fabricating techniques
including melt casting, extrusion molding, etc. The
resin may have incorporated therein, as desired,
conventional stabilizers, radiopaque materials such as
barium sulfate, and the like. The amounts of these
materials will vary depending upon the application of
the polyurethane, but they are typically present in
amounts ranging from about 25 to 40 weight percent of
the polymer.
Tensile strength is a measure of the force,
generally given in pounds per square inch (psi)
required to break a polymer. Elongation is a measure
of the ability of a polymer to stretch without
breaking, and is generally reported as a percentage of
an initial value. The term modulus defines the force,
in psi, required to stretch a polymer to a given
percentage of elongation.
The tensile, elongation and modulus of the P W of
2~ the invention may be measured by ASTM procedure D638
using an Instron Universal Testing Instrument, Model
1122. Representative polymers of the invention are
given, along With their physical properties, hard
segment (HS) content and isocyanate index (II), in the
Charts below.
_
13 201 4035
The following Examples are provided to further describe the
invention but are not to be considered in any way to be
limitative of the invention.
EXAMPLE I
One Step Bulk PolYmerization
PTMO 1000 (350 g) was mixed with 4.96 g each of MPMD and
ethylene glycol. With rapid stirring, 140.1 g of MDI was added
all at once. The mixture was stirred for three minutes while the
temperature rose to lOO-C. The clear hot melt was spread on a
tray and cured in an oven at 125C for one hour, then allowed to
post cure in moist air at ambient temperature for two days.
201 4035
14
EXAMPLE II
one Shot Bulk Polymerization
PTMO 1000 (350 g) was mixed with 1.66 g of water and 5.55
g each of MPMD and BDO. MDI (138.9 g) was added all at once with
rapid stirring, and stirring continued for two minutes. The
resulting polymer was spread on a tray and cured in a 125-C oven
for one hour. The polymer slab was allowed to post cure under
ambient conditions.
EXAMPLE III
One Step Bulk Polymerization
A mixture of PTMO 1000 (332.5 g), 17.5 g of Q-4 2000, and
4.49 g each of MPMD and BDO was reacted with rapid stirring with
141.0 g of MDI for two minutes.
~-. 201 4035
The reæulting polymer was spread on a tray and cured in a 125c
oven for one hour. The polymer slab was allowed to post cure in
moist air.
EXAMPLE IV
One Shot Bulk Polymerization
PTMO 1000 (350 g) was mixed with 125 g of barium sulfate.
Water (1.48 g) and 2.92 g each of MPMD and BDO were added and
the mixture treated all at once with 141.0 g of MDI with rapid
stirring. After stirring for two minutes, the resulting polymer
was spread on a tray and cured in a 125C oven for one hour. The
polymer slab was allowed to post cure in moist air.
EXAMPLE V
One Shot Bulk Polymerization
PTMO 1000 (350 g) was mixed thoroughly with 125 g of barium
sulfate. Q-4-2000 (17.5 g), 1.48 g of water and 4.49 g each of
MPMD and BDO were added, followed by 141.0 g MDI added all at
once with rapid stirring. After stirring for two minutes, the
resulting polymer was spread on a tray and cured in a 125C oven
for one hour. The polymer slab was allowed to post cure under
ambient conditions.
The polymers in the following chart are representative of
the polymers of the invention and
,.~
201 4035
were prepared by the method of E.Yamples I - V usulg an II of 120.
IENSLE
GLYCOL EXIENDERS MODULUS ELONG
~10 .~W WT DIOL WT DIAM- Wl MDI HS. psi psi AIION
g) (g) INE (g) % (lCPa) (}CPa) %
at S~a
PrM~ 3S0 BDO 3.13 ?.1PMD 3.13 168.7 33
6S0
2 PTMO- 37S BDO 1.38 MPMD 1.38 122.2 2S
1000
3 PlMO- 3S0 BDO 12.S8 ~SPMD 12.S8 124.8 3U S 110 320 11~0 2000 (37.3) (7.2)
PIMO- 37S BDO 11.04 MPMD 11.04 102.9 2S
2900
S PEa 325 8DO l.S7 MPMD l.S7 112.0 3S
600
6 PEG- 3S0 8DO 9.6S MPMD 9.65 130.7 30
1~50
7 PEa 37S BDO 11.6S MPMD II.S8 101.8 2S
3SS0
8 PEG ;S0 BDO 1~.6S MPMD 17.79 114.4 30
8000
9 PIM~ 3S0 BDO ~.29 EDA 4.29 141.4 30 907 12S 878
1000 S6.3) (0.9)
PTMO- 3S0 BDO S.48 HDA S.18 139. 30
1000
Il PTMO- 3S0 BDO 6.02 ODA 6.02 137.9 30 ~IIK 279 S18
1000 as.s) (1.9)
12 PIMO- 3S0 8DO 7.00 DDA 7.00 136.0 30
10Q0
13 PTMO- 3S0 BDO 7.92 MP~) 2.64 139.4 30 1723 3 IS S80
1000 - (32.6) (2.2)
14 PrMO- 3S0 BDO 2.91 MPMD 8.70 138.4 30 2974 3 IS S80
1000 (20 S) (2.2)
IS P~MO- 3S0 EG 7.22 ~PMD 7.22 13S.8 30 231 S9 IS00
1000 (1.6) (0.4)
16 P'IMO- 3S0 EG 6.39 ~MD 2.13 139.4 30 '~918 308 S93
10Q0 (33.9) (2.1)
17 PIMO- 3S0 EG 2.73 MPMD 8 20 139.0 30 ~589 ;86 S70
10Q0 (31.6) (2.7)
18 P~ 3S0 BDO 8.SS MPMD 8.SS 132.9 30
1000
19 PTMO- 37S BDO 1.38 ~PMD 1.38 122.2 2S
1000
'O P7~10- ;00 BDO 13.9 MPMD 13.9 172.8 ~0
1000
Thus, the invention inc~ es the~nopl~shc melt yl~cess~ble PWs
which in~ fle diol ~ n~l~r blocks and r~ e ~n~l~r blocks in the
polymer chain The polyrners are made by a facile one-pot, one-shot,
solvent free, catalyst-free process.
